Compositions for combating nicotinism in man

Claim 2

A composition for combating nicotinism, comprising: 10-15% by wt. dry extract of valerian in an amount sufficient to modify the gustatory and olfactory sensations, 6.5- 15% by wt. vitamin B 1 in an amount sufficient to correct disturbed glucidic metabolism; 30-55% by wt. vitamin B 6 in an amount sufficient to correct neuritis and trembling resulting from the deprivation of nicotine; 3- 40% by wt. ascorbic acid in an amount sufficient to compensate for the fall in the amount of ascorbic acid in the biological media of smokers, and a sufficient quantity of pharmaceutically acceptable excipient to give 100%.

Claim 3

A composition in accordance with claim 1 in the form of an orally administrable tablet, gelatin capsule or pill.

Claim 4

A composition in accordance with claim 2 wherein said tablet, gelatin capsule or pill is coated with a gastro-resistant glaze.

Claim 5

A composition for combating nicotinism, comprising: 10-15% by wt. dry extract of valerian in an amount sufficient to modify the gustatory and olfactory sensations; 6.5-15% by wt. vitamin B 1 in an amount sufficient to correct disturbed glucidic metabolism; 30-55% by wt. vitamin B 6 in an amount sufficient to correct neuritis and trembling resulting from the deprivation of nicotine; 10-15% by wt. anti-insomnia agent in a quantity sufficient to induce sleep, and a sufficient quantity of pharmaceutically acceptable excipient to give 100%.

Claim 6

A composition for combating nicotinism, comprising: 10-15% by wt. dry extract of valerian in an amount sufficient to modify the gustatory and olfactory sensations; 6.5-15% by wt. vitamin B 1 in an amount sufficient to correct disturbed glucidic metabolism; 30-55% by wt. vitamin B 6 in an amount sufficient to correct neuritis and trembling resulting from the deprivation of nicotine; 10-15% by wt. anti-insomnia agent in a quantity sufficient to induce sleep, and a sufficient quantity of pharmaceutically acceptable excipient to give 100%.

Claim 7

A composition in accordance with claim 4 wherein said anti-insomnia agent comprises sodium secobarbital.

Claim 8

A composition in accordance with claim 4 wherein said anti-insomnia agent comprises sodium secobarbital.

Claim 9

A composition in accordance with claim 4 in the form of an orally administrable tablet, gelatin capsule or pill.

Claim 10

Process for combating nicotinism in humans, comprising: orally administering in the daytime a composition comprising: 10-15% by weight dry extract of valerian; 6.5-15% by weight vitamin B 1 ; 30-55% by weight vitamin B 6 ; 30-40% by weight ascorbic acid; and a sufficient quantity of pharmaceutically acceptable excipient to give 100%; orally administering at night a composition, comprising: 1- 15% by weight dry extract valerian; 6.5-15% by weight vitamin B 1 ; 30-55% by weight vitamin B 6 ; 10-15% by weight anti-insomnia agent; and a sufficient quantity of pharmaceutically acceptable excipient to give 100%; wherein the combined daily dose of said compositions is in an amount effective to combat nicotinism.

Claim 11

Process for combating nicotinism in humans, comprising: orally administering in the daytime a composition comprising: 10-15% by weight dry extract of valerian; 6.5-15% by weight vitamin B 1 ; 30-55% by weight vitamin B 6 ; 30-40% by weight ascorbic acid; and a sufficient quantity of pharmaceutically acceptable excipient to give 100%; orally administering at night a composition, comprising: 1- 15% by weight dry extract valerian; 6.5-15% by weight vitamin B 1 ; 30-55% by weight vitamin B 6 ; 10-15% by weight anti-insomnia agent; and a sufficient quantity of pharmaceutically acceptable excipient to give 100%; wherein the combined daily dose of said compositions is in an amount effective to combat nicotinism.

Claim 12

A method in accordance with claim 8 wherein said anti-insomnia agent comprises sodium secobarbital.